Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Uro Gen Pharma Ltd. Transaction History
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD
- $434 Million
- Q2 2025
A detailed history of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD holds 21,823 shares of URGN stock, worth $441,915. This represents 0.07% of its overall portfolio holdings.
Number of Shares
21,823
Previous 21,823
-0.0%
Holding current value
$441,915
Previous $241,000
23.65%
% of portfolio
0.07%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
163Shares Held
39.6MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$92 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$64.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$50.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$44.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$44.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $460M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...